Home › Researcher directory › Sarah Benchabane
Sarah Benchabane
Affiliation : University of Sciences and Technology Houari Boumediene
- 7Publications (affiliation in Algeria)
- 8Total publications
- 108Citations
- 6h-index
Research profile
Sarah Benchabane has 7 indexed publications (2018–2026). Their work appears mainly in “Endocrine Metabolic & Immune Disorders - Drug Targets”, “Clinical Immunology” and “International Journal of Immunopathology and Pharmacology”. Their most cited article, “Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren’s syndrome” (2018), has been cited 19 times. 2 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Salivary Gland Disorders and Functions
- Systemic Lupus Erythematosus Research
- Ocular Surface and Contact Lens
- Rheumatoid Arthritis Research and Therapies
- Ocular Diseases and Behçet’s Syndrome
Publications (7)
- Metabolic syndrome and increased inflammatory burden in active rheumatoid arthritis: An exploratory focus on hematologic markers
- Exploring the relationship between oxidative stress status and inflammatory markers during primary Sjögren’s syndrome: A new approach for patient monitoring
- Increased Salivary Cytokines and Nitric Oxide Levels in Behçet’s Disease: Interleukin-32, a Novel Player in Disease Prognosis
- Association between Increased Bcl-2, Fas and FasL Levels and Inflammation Extent in Labial Salivary Glands During Primary Sjögren's Syndrome
- In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease
- Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren’s syndrome
- Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren’s syndrome
Publication venues
- Endocrine Metabolic & Immune Disorders - Drug Targets × 2
- Clinical Immunology × 1
- International Journal of Immunopathology and Pharmacology × 1
- International Immunopharmacology × 1
- Immunopharmacology and Immunotoxicology × 1
- Inflammopharmacology × 1
Publications per year
- 20261
- 20241
- 20221
- 20212
- 20182
Collaborations
Partner institutions : Hôpital Mustapha Pacha · University of Algiers Benyoucef Benkhedda · University of Guelma · University of Blida · Institut Pasteur d'Algérie
Co-authors
- Chafia Touil–Boukoffa
- Houda Belguendouz
- Zohra Hadjimi
- Amina Arroul-Lammali
- Sourour Zidi
- Fifi Otmani
- Sarah Ihammichene
- Lyazidi Nabila
- Amel Bouzenad
- Lamia Ali Pacha
- Zineb Djeraba
- Arezki Samer
Bibliographic data from OpenAlex (open database).
Why choose DzCademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.